☆ 4.7 Editorial Material

Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Fingerprint

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients

Gulzhanat Aimagambetova et al.

Summary: Incidence of endometrial cancer has been increasing in recent years, especially in high-income countries. Fertility-sparing treatment for young patients with EC has become extremely important due to increasing incidence among reproductive age women. Several fertility-sparing options, including medication, minimally invasive surgical techniques, and the utilization of molecular biomarkers, have been developed and found to be efficient for fertility preservation.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review

Panayiotis Tanos et al.

Summary: Endometrial cancer has a high incidence in women under 40 years old, and the decision of fertility preservation in early stage endometrial cancer is challenging. Many patients wish to have children after successful treatment. This review identifies genetic prognostic factors that can aid in decision-making for fertility-sparing treatment in early stage endometrial cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions

Nayanar-Adela Contreras et al.

Summary: Endometrial cancer is the fourth most common cancer in women in developed countries. Its incidence has increased in young women, possibly due to factors such as delayed childbearing and obesity. The new molecular classification of the disease helps personalize treatment. Current evidence suggests that oral progestin alone or in combination with other drugs is a feasible and safe option for the conservative management of early-stage endometrial cancer limited to the endometrium.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Leptin and Adiponectin in Endometrial Cancer

Aneta Slabuszewska-Jozwiak et al.

Summary: Obesity is strongly associated with the development of endometrial cancer, and adipokines such as adiponectin and leptin may play a role in this process. Understanding the signaling pathway of these cytokines in endometrial cancerogenesis could potentially lead to targeted therapies and fertility-sparing treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Medicine, General & Internal

Endometrial cancer

Emma J. Crosbie et al.

Summary: Endometrial cancer is the most common gynaecological cancer in high income countries, with a global rise in incidence. Obesity is the major underlying cause, posing challenges for diagnosis and treatment. Early presentation with postmenopausal bleeding ensures cure, but advanced cases have poor prognosis. Minimally invasive surgical staging and targeted chemotherapeutic strategies are important advances.

LANCET (2022)

Add to Collection

Review Acoustics

Three-dimensional transvaginal ultrasound vs magnetic resonance imaging for preoperative staging of deep myometrial and cervical invasion in patients with endometrial cancer: systematic review and meta-analysis

G. Spagnol et al.

Summary: This study evaluated and compared the diagnostic test accuracy of three-dimensional transvaginal ultrasound (3D-TVS) and magnetic resonance imaging (MRI) for deep myometrial infiltration (DMI) and cervical invasion in patients with endometrial cancer (EC). The results showed that 3D-TVS demonstrated good sensitivity and specificity for the evaluation of DMI and cervical invasion, with comparable results to MRI.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer

Piotr Olcha et al.

Summary: Endometrial cancer (EC) is a commonly diagnosed malignant tumor in the female reproductive system. Literature suggests that 32 genes are involved in the hereditary incidence of EC. The physiological markers of EC include disorders in the antioxidative system and inflammation. A diet rich in substances aiding the response to this disorder, particularly those suitable for lifelong consumption, is important for prophylaxis and pharmacotherapy. Tea polyphenols have proven antioxidative, anti-inflammatory, anti-obesogenic, and antidiabetic properties, making tea consumption beneficial for individuals genetically predisposed for EC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review

Pierluigi Giampaolino et al.

Summary: Conservative treatment may be an option for patients with Stage IA G2 endometrioid endometrial cancer who desire to preserve their fertility. Evaluation of immunohistochemical markers shows promise in predicting response to conservative treatment. Further large series and randomized clinical trials are needed to confirm these results.

BIOMED RESEARCH INTERNATIONAL (2022)

Add to Collection

Review Oncology

Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes

Levent Mutlu et al.

Summary: Young women diagnosed with endometrial cancer face unique challenges, but preserving fertility is possible in early and low-grade cases. Data suggest that conservative approaches with close monitoring do not compromise oncologic outcomes. For patients unable to preserve fertility, assisted reproductive technologies can help achieve fertility goals.

CANCERS (2022)

Add to Collection

Article Medicine, General & Internal

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

Basilio Pecorino et al.

Summary: The study evaluated the survival and relapse rates of women with endometrioid ovarian cancer and SEO-EC, finding that even without signs of lymph node involvement, patients who underwent pelvic and para-aortic lymphadenectomy did not have a lower relapse rate.

MEDICINA-LITHUANIA (2022)

Add to Collection

Review Medicine, General & Internal

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women

Stefano Uccella et al.

Summary: Fertility-sparing management is feasible for atypical endometrial hyperplasia and early-stage endometrial cancer, but strict follow-up and specific conditions are necessary.

MEDICINA-LITHUANIA (2022)

Add to Collection

Review Oncology

Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes

Jessica Lauren Floyd et al.

Summary: For women with early-stage gynecologic cancer, fertility-sparing treatments may be an option but require careful consideration of potential risks and benefits by both patients and healthcare providers. Patients undergoing fertility-sparing therapies may experience fertility and obstetric complications, highlighting the importance of preconception counseling with high-risk obstetric specialists. Collaboration between gynecologic oncologists and fertility specialists is essential for identifying appropriate candidates for fertility-sparing treatments and helping women conceive after cancer treatment.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Add to Collection

Article Oncology

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin et al.

Summary: The European consensus conference on endometrial carcinoma in 2014 aimed to produce multi-disciplinary evidence-based guidelines. Since then, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) have decided to update the guidelines and cover new topics to improve care for women with endometrial carcinoma globally.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Add to Collection

Review Oncology

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

Jutta Huvila et al.

Summary: Endometrial carcinoma has various morphological variants with distinct molecular abnormalities. Early diagnosis of the rare recognized precursor lesions is crucial for the relatively favorable prognosis of EC.

JOURNAL OF PATHOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification

Anna Franca Cavaliere et al.

Summary: Endometrial cancer is the most common gynecological malignancy, and fertility sparing treatments offer hope for young cancer patients who wish to preserve their ability to have children while undergoing treatment. Advances in molecular biology and the refined clinical and prognostic classification of endometrial cancer based on The Cancer Genome Atlas allow for the selection of patients who can undergo fertility sparing treatments with increased oncological safety.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview

Giuseppe Gullo et al.

Summary: Fertility-sparing approach is suitable for early-stage Type I EC, with emphasis on pharmaceutical treatment and follow-up.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Medicine, General & Internal

Fertility-sparing management for endometrial cancer: review of the literature

Simone Garzon et al.

Summary: Fertility preservation appears feasible in young patients with grade 1 EC limited to the endometrium or atypical endometrial hyperplasia. Progestins are the mainstay of such management. The addition of Metformin and hysteroscopic resection seems to provide some improvements. However, fertility preservation is not the standard approach for staging and treatment, potentially worsening oncologic outcomes.

MINERVA MEDICA (2021)

Add to Collection

Review Medicine, General & Internal

New development on hysteroscopy for endometrial cancer diagnosis: state of the art

Jose Carugno et al.

Summary: Endometrial cancer has two subtypes, with Type I tumors being more common and linked to estrogen exposure, with better prognosis, while Type II tumors are less common and associated with poor prognosis. The use of hysteroscopy for endometrial biopsy provides significant advantages.

MINERVA MEDICA (2021)

Add to Collection

Review Medicine, General & Internal

Novelties of ultrasound imaging for endometrial cancer preoperative workup

Vito A. Capozzi et al.

Summary: TVU shows sensitivity and specificity in myometrial infiltration and cervical invasion comparable to MRI, with lower costs, better patient tolerability, and no need for contrast agents. An expert operator should perform the ultrasound examination in suspected EC patients. Special attention should be paid to patients with concurrent uterine lesions such as leiomyomas, as they may affect the accuracy of the ultrasound diagnosis.

MINERVA MEDICA (2021)

Add to Collection

Review Oncology

The Perspectives of Fertility Preservation in Women with Endometrial Cancer

Jure Knez et al.

Summary: Endometrial cancer is the most common gynecological cancer in developed countries and is increasingly diagnosed in younger women of reproductive age. The standard treatment involves surgical removal, which may impact future fertility for younger women. The current challenge is to identify low-risk patients who could benefit from more conservative treatment options while focusing on preserving quality of life. Future studies should focus on identifying reliable clinical and molecular predictive markers to expand the use of fertility-preserving treatment methods.

CANCERS (2021)

Add to Collection

Article Oncology

Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer

Marta Lukasiewicz et al.

Summary: The number of EC cases is increasing, and current diagnostic methods are not precise enough, leading to delayed diagnosis until after surgery. Liquid biopsy coupled with artificial intelligence may provide a solution, as shown in this study.

CANCERS (2021)

Add to Collection

Article Oncology

Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer?

Attilio Di Spiezio Sardo et al.

GYNECOLOGIC ONCOLOGY (2020)

Add to Collection

Article Oncology

Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged <= 40 years

Ji Son et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Add to Collection

Article Oncology

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

Marco Benati et al.

PATHOLOGY & ONCOLOGY RESEARCH (2020)

Add to Collection

Review Obstetrics & Gynecology

The use of hysteroscopy in endometrial cancer: old questions and novel challenges

P. Torok et al.

CLIMACTERIC (2020)

Add to Collection

Review Biochemistry & Molecular Biology

New clinical targets ofd-chiro-inositol: rationale and potential applications

Antonio Simone Lagana et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)

Add to Collection

Article Oncology

Endometrial cancer: a genetic point of view

Bianca Bianco et al.

TRANSLATIONAL CANCER RESEARCH (2020)

Add to Collection

Review Oncology

Endometrial cancer-is our knowledge changing?

Milena Kralickova et al.

TRANSLATIONAL CANCER RESEARCH (2020)

Add to Collection

Review Multidisciplinary Sciences

Signs and symptoms associated with uterine cancer in pre- and postmenopausal women

Shari Boeckstaens et al.

HELIYON (2020)

Add to Collection

Article Endocrinology & Metabolism

Myo-inositol and melatonin in the menopausal transition

Rosario D'Anna et al.

GYNECOLOGICAL ENDOCRINOLOGY (2017)

Add to Collection

Article Surgery

Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up

Pietro Cignini et al.

UPDATES IN SURGERY (2017)

Add to Collection

Review Surgery

Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives

Salvatore Giovanni Vitale et al.

UPDATES IN SURGERY (2017)

Add to Collection

Review Obstetrics & Gynecology

Treatment strategies for endometrial cancer: current practice and perspective

Yeh C. Lee et al.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2017)

Add to Collection

Review Obstetrics & Gynecology

Genetics of Endometrial Cancers

Tsuyoshi Okuda et al.

OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.